Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

HomeCancerProstate

Prostate

Mixed microfluidic enrichment and marking workflow for single-cell evaluation of circulating tumor cells in metastatic prostate most cancers sufferers

Affected person samplesAs much as 20 mL blood was collected in CellRescue™ Preservative Tubes (Menarini Silicon Biosystems) from sufferers with disseminated prostate most cancers...

Cruisin’ for the Treatment returns to Bonanza On line casino to assist prostate most cancers analysis

RENO, Nev. (KOLO) - Northern Nevada’s most impactful automobile present returns this weekend. Bonanza On line casino’s Cruisin’ for the Treatment advantages the...

Flotufolastat F 18 reveals promising diagnostic efficiency in Black males with prostate most cancers

Flotufolastat F 18 (US commerce title, Posluma) demonstrated promising diagnostic efficiency in African American males with recurrent prostate most cancers, in accordance with...

Various splicing in prostate most cancers development and therapeutic resistance

Siegel RL, Giaquinto AN, Jemal A. Most cancers statistics, 2024. CA Most cancers J Clin. 2024;74:12–49.Article  PubMed  ...

Blue Earth Diagnostics, a Bracco Firm, Proclaims Outcomes Evaluating Diagnostic Efficiency of POSLUMA® (Flotufolastat F 18) and Scientific Trial Enrollment in African American Males...

Blue Earth Diagnostics, a Bracco Firm, Proclaims Outcomes Evaluating Diagnostic Efficiency of POSLUMA® (Flotufolastat F 18) and Scientific Trial Enrollment in African American...

Hot Topics